Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
about
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophiesModifier genes and their effect on Duchenne muscular dystrophy204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The NetherlandsAge at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.Management of cardiac involvement in muscular dystrophies: paediatric versus adult formsOsteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscleThe EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseasesPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsAsynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophyGenetic Modifiers for Neuromuscular DiseasesGenetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History StudyGenetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever ModelDMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter studyAssociation Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.Circulating Biomarkers for Duchenne Muscular Dystrophy.Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategiesVariations in Duchenne muscular dystrophy course in a multi-ethnic UK population: potential influence of socio-economic factors.Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.Outside in: The matrix as a modifier of muscular dystrophy.Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells.226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells.Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy.
P2860
Q26795772-2B45B0C1-F4FA-44E0-AD94-C1B6CB53BC8BQ28083441-0BD8B7A3-71F2-4DB9-8B8A-AF08D6F595F2Q28611318-0F6F6C8F-00EE-4124-99AC-7E4E8C3FF6DDQ31056857-D82F9FCD-C9AB-4E4B-BD6F-B4911D19D038Q33635762-813AD45D-55DE-4F99-BCC5-32A312C2BEA3Q33635766-4F0A779F-83F2-4E9E-93D4-ABA6080799CCQ33779868-C0786F66-6F1E-40C5-8240-AC9F28D2A84CQ34042850-0FE1C832-EA88-4EAB-9945-E539595617CEQ34152280-4AE50264-4E3E-4139-A70E-477D1E0D47CFQ34332718-3B4C7269-E91D-4AA8-83CC-018734D319A7Q34424160-477329C2-E775-474C-A008-341DFBDFE07FQ35119976-343B6349-4310-4DF4-9270-5200CD773828Q35495274-FCE6CD3E-F58F-4232-BB22-F85176872452Q35826211-55EC306D-CF7A-463D-BC33-15CB2FDB5D52Q36150125-731C654A-121C-438D-B5FC-90E1AF377187Q36155677-DEA5ED61-803A-4C19-97A7-66C78868C230Q36334428-0209ED0A-CF1D-4C20-9448-FACE5E17F2A6Q36344905-FB674C89-22D4-4148-91E4-E3450AA2C13EQ36577433-8A0A0C07-FA2A-4365-94B3-37228A7A25A4Q37148808-2E13A66E-535F-4C87-AD56-0A3DDB81A91AQ37158951-FB599134-5647-410C-95F6-F2573BAE9CB4Q37298079-8F55E3F6-B2C5-4370-980A-7661237517A9Q37396900-1B146B96-C78C-4DAF-B407-2837B073C7F9Q37610530-EA2DF8A5-F82E-4DE9-A643-4FBC57F08EDEQ38541264-7CA18173-6BF5-4120-88C3-30F9810A4763Q38783404-D62C7EF9-6D00-445B-A473-34C3D04732F3Q38816248-35A448DF-0C9B-4E64-B6A8-F338E5F34EC1Q39052032-1D9AB82D-624D-4FF8-A76C-2B219BFC314FQ44907195-CD01A175-6DAD-4464-94D2-A26E4A824708Q45874288-ACB92D0B-DF98-4CEE-A548-3470D6C3D00CQ47153959-D3AA64A5-C427-46D9-97C6-5207AB3FAA58Q48543939-F936FD9D-2B53-47BB-8B6F-93E09E58A2B5Q50953438-7CBAF0F3-A14B-4E2A-8FA5-152FF2E3AA6BQ52372774-5475D0EA-82FC-409A-B680-8AEA91482681Q54988224-267B0E78-70FE-46AE-B50E-EFF283F315A5
P2860
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@ast
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@en
type
label
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@ast
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@en
prefLabel
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@ast
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@en
P2093
P2860
P50
P1433
P1476
Importance of SPP1 genotype as ...... in Duchenne muscular dystrophy
@en
P2093
Adele D'Amico
Alessandra Ferlini
Andrea Barp
Angela Berardinelli
Antonella Taglia
Carlo Minetti
Claudio Bruno
Elena Pegoraro
Elisabetta Gazzerro
Eric P Hoffman
P2860
P304
P356
10.1212/WNL.0B013E31825F04EA
P407
P50
P577
2012-06-27T00:00:00Z